Pharmacokinetic behavior of L-asparaginase in men and in animals.
D000818:Animals; D000917:Antibody Formation; D001215:Asparaginase / Q000008:administration & dosage / Q000097:blood* / Q000378:metabolism; D002403:Cathepsins; D002417:Cattle; D004285:Dogs; D006207:Half-Life; D006801:Humans; D007273:Injections, Intramuscular; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007668:Kidney / Q000201:enzymology; D007700:Kinetics; D008099:Liver / Q000201:enzymology; D051379:Mice; D008815:Mice, Inbred Strains; D009206:Myocardium / Q000201:enzymology; D009374:Neoplasms, Experimental / Q000201:enzymology / Q000378:metabolism; D011817:Rabbits / Q000276:immunology; D051381:Rats; D013045:Species Specificity; D013154:Spleen / Q000201:enzymology
D002403:Cathepsins; D001215:Asparaginase